人工智能心电图预测心力衰竭:HeartShare/AMP-HF汇总队列分析
该研究汇总Framingham心脏研究、动脉粥样硬化多种族研究与心血管健康研究的14126例参与者数据,评估用于检出收缩和舒张功能不全的ECG-AI对心力衰竭发病的预测价值。结果显示,在PREVENT-HF临床风险评分基础上加入ECG-AI可改善近期心力衰竭风险的区分度与重分类能力。
要点
- 在PREVENT-HF风险基础上加入ECG-AI可改善近期心衰风险区分度。
- 复合ECG-AI筛查阳性者发生心衰的风险远高于筛查阴性者。
- ECG-AI有助于人群层面心衰危险分层与针对性预防。
核心结论
- 在PREVENT-HF模型中加入ECG-AI可改善近期心力衰竭风险的区分度,并可能支持人群层面心衰危险分层与针对性预防策略。
研究设计与样本
- 研究汇总了Framingham心脏研究、动脉粥样硬化多种族研究与心血管健康研究的基线临床和心电图数据。
- 纳入具有足够数据同时完成ECG-AI评估和PREVENT-HF评估的参与者,共14126例。
- 分析于2025年7月至9月在美国国家心肺血液研究所BioDataCatalyst平台完成。
主要发现
- ECG-AI LEF阳性筛查率为2.9%,ECG-AI DD为11.1%,复合ECG-AI模型为11.9%。
- PREVENT-HF评分≥10%者占25.1%,PREVENT-HF评分≥20%者占5.8%。
- 7.7%的参与者发生心力衰竭,15.1%的参与者死亡。
- 基线复合ECG-AI筛查阳性者发生心衰的风险是筛查阴性者的10至20倍。
关键数值与推荐
- 在PREVENT-HF阈值为10%时,加入ECG-AI后1、3、5、10年单向净重分类改善为0.086至0.125。
- 在PREVENT-HF阈值为20%时,加入ECG-AI后1、3、5、10年单向净重分类改善为0.327至0.403。
临床怎么用
- ECG-AI可作为人群层面心力衰竭危险分层的工具,用于识别近期心衰风险较高的个体并指导预防干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Artificial intelligence applied to electrocardiograms (ECG-AI) offers a scalable approach to identify individuals at risk for heart failure (HF) and guide preventive interventions. OBJECTIVES: The purpose of this study was to assess whether ECG-AI designed to detect systolic and diastolic dysfunction enhances the prediction of incident HF over clinical risk estimation using the PREVENT-HF (Predicting Risk of Cardiovascular Disease EVENTs-Heart Failure) equation. METHODS: Baseline clinical and electrocardiogram data were pooled from the Framingham Heart Study, Multi-Ethnic Study of Atherosclerosis, and Cardiovascular Health Study. Participants with data sufficient for both ECG-AI and PREVENT-HF assessment were included. Analyses were performed on the National Heart, Lung, and Blood Institute BioDataCatalyst from July to September 2025. Risk of incident HF was estimated using previously validated ECG-AI algorithms that detect systolic (ECG-AI LEF) and diastolic (ECG-AI DD) dysfunction. Discrimination and reclassification were evaluated using Harrell's C-statistic and net reclassification improvement. RESULTS: Of 14,126 participants, positive screening rates were 2.9% for ECG-AI LEF, 11.1% for ECG-AI DD, 11.9% for the composite ECG-AI model, 25.1% for PREVENT-HF score ≥10%, and 5.8% for PREVENT-HF score ≥20%. Incident HF or death occurred in 7.7% and 15.1% of participants, respectively. Participants with positive composite ECG-AI screens at baseline had 10- to 20-fold higher risk of developing HF compared with those with negative screens. At 1, 3, 5, and 10 years, the addition of ECG-AI to PREVENT-HF yielded 1-directional net reclassification improvements ranging from 0.086 to 0.125 at a PREVENT-HF threshold of 10%, and 0.327 to 0.403 at a threshold of 20%. CONCLUSIONS: The addition of ECG-AI to PREVENT-HF improved discrimination of near-term HF risk. ECG-AI may enable population-level HF risk stratification and facilitate targeted prevention strategies.
引用
- Desai, Pandey, Suratekar, et al. Predicting Heart Failure From 12-Lead ECGs Using AI: A HeartShare/AMP-HF Pooled Cohort Analysis. J Am Coll Cardiol. 2025. PMID: 41493294. doi:10.1016/j.jacc.2025.10.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。